stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Gross margin
STERIS plc's gross margin over the twelve months to 30 September 2026 was 44.6%, up 0.3 percentage points from fiscal 2026 (44.3%). Over the past ten years it has ranged from 39.3% (fiscal 2017) to 44.6% (fiscal 2022); the current reading is higher than 92% of that period. That is below the Medical Devices industry median of 57.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 44.3% | 0.24 |
| FY2025 | 44.0% | 0.85 |
| FY2024 | 43.2% | (0.50) |
| FY2023 | 43.7% | (0.93) |
| FY2022 | 44.6% | 1.37 |
| FY2021 | 43.2% | (0.33) |
| FY2020 | 43.6% | 1.32 |
| FY2019 | 42.2% | 0.52 |
| FY2018 | 41.7% | 2.43 |
| FY2017 | 39.3% | (0.72) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 44.7% | (1.10) |
| Jun 2026 | 45.8% | 1.95 |
| Mar 2026 | 43.9% | 0.08 |
| Dec 2025 | 43.8% | (0.42) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation compare | 81.1% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.7% |
| GMED Globus Medical, Inc. compare | 69.1% |
| PEN Penumbra, Inc. compare | 68.0% |
| DXCM DexCom, Inc. compare | 63.4% |
| PHG Koninklijke Philips N.V. compare | 46.4% |
| STE STERIS plc | 44.6% |
| GEHC GE HealthCare Technologies Inc. compare | 40.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement